Skip to content

Medical emergency? What to do

U.S. drug makers to review advertising complaints

3-RXPublished August 3, 20052 min read

Key points

  • Drug makers will set up an office to review complaints about the marketing of prescription drugs, industry officials said on Tuesday as they moved to quiet rising criticism of glitzy commercials and magazine ads.
  • The guidelines urge companies to "spend an appropriate amount of time" educating doctors about new medicines before promoting them to consumers, according to a statement from the Pharmaceutical Research and Manufacturers of America, or PhRMA.
  • PhRMA will establish an "Office of Accountability" to receive comments from consumers and doctors.
  • A broad outline of the guidelines was unveiled last month.

Drug makers will set up an office to review complaints about the marketing of prescription drugs, industry officials said on Tuesday as they moved to quiet rising criticism of glitzy commercials and magazine ads.

That pledge, and voluntary guidelines urging balanced and informative ads, failed to appease critics who say drug promotions exaggerate the benefits of some drugs and prompt unnecessary prescribing to patients who may not need them.

The guidelines urge companies to "spend an appropriate amount of time" educating doctors about new medicines before promoting them to consumers, according to a statement from the Pharmaceutical Research and Manufacturers of America, or PhRMA. They do not establish a specific a waiting period, as some critics have advocated.

"We are committing to the American people and the medical community that we will use advertising not only to promote new medicines, but also to educate consumers about health and disease," Johnson & Johnson Chairman and Chief Executive William Weldon said.

PhRMA will establish an "Office of Accountability" to receive comments from consumers and doctors. The office will report to the public on those comments and companies' responses. After a year, an independent panel will review the information and make recommendations, a PhRMA statement said.

PhRMA's "guiding principles" state that ads aimed at consumers "should be accurate and not misleading, make claims only when supported by substantial evidence, reflect balance between risks and benefits and be consistent with (Food and Drug Administration)-approved labeling."

A broad outline of the guidelines was unveiled last month. Top industry officials were set to announce details at a conference in Dallas on Tuesday.

Consumer advocate Dr. Sidney Wolfe, director of Public Citizen's Health Research Group, said PhRMA's efforts were "a meaningless attempt to fool people into believing the guidelines are stronger than they really are."

Dr. Wolfe said regulators should beef up enforcement of rules requiring ads to be accurate and balanced. Television ads should receive FDA approval before they air, and the agency should have the power to fine companies for violating ad rules, he said.

Pharmaceutical companies spent $3.3 billion on ads aimed at consumers in 2003, according to medical data company IMS Health. Research and development spending was $33.2 billion in the same year.

The new guidelines will take effect in January. Each company will decide separately whether to follow them, PhRMA said.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.